title: Impact of polymorphisms affecting the ACP1 gene on levels of antibodies against platelet factor 4-heparin complexes.
authors.forename: J
authors.initials: J
authors.lastname: Rollin
authors.forename: C
authors.initials: C
authors.lastname: Pouplard
authors.forename: D
authors.initials: D
authors.lastname: Leroux
authors.forename: M-A
authors.initials: MA
authors.lastname: May
authors.forename: Y
authors.initials: Y
authors.lastname: Gruel
mesh_terms: D000483:Alleles; D000906:Antibodies / Q000276:immunology*; D004797:Enzyme-Linked Immunosorbent Assay; D005838:Genotype; D006493:Heparin / Q000009:adverse effects* / Q000276:immunology; D006801:Humans; D010978:Platelet Factor 4 / Q000276:immunology*; D011110:Polymorphism, Genetic; D017027:Protein Tyrosine Phosphatases / Q000235:genetics*; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D012306:Risk; D015398:Signal Transduction; D013921:Thrombocytopenia / Q000139:chemically induced / Q000235:genetics / Q000276:immunology*
chemical_list: D000906:Antibodies; D011518:Proto-Oncogene Proteins; D010978:Platelet Factor 4; D006493:Heparin; C490429:ACP1 protein, human; D017027:Protein Tyrosine Phosphatases